Establishing a fecal microbiota transplant service for the treatment of clostridium difficile infection

98Citations
Citations of this article
115Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Recurrent or refractory Clostridium difficile infection (CDI) has become an increasing problem in the past decade. Fecal microbiota transplant (FMT) is a highly efficacious treatment for recurrent CDI; however, a number of technical, logistical, and regulatory issues have hampered the development of an FMT capability at many hospitals. The development of a frozen stool bank of screened donor stool is an important step in the standardization of the procedure. This gives clinicians rapid access to thoroughly screened donor stool when needed, without the ethical and logistical problems associated with patient-selected donors. We describe the practicalities of establishing such a service using a stool bank of prescreened donor stool including detail regarding donor recruitment and screening, stool preparation, and delivery of the FMT.

Cite

CITATION STYLE

APA

Costello, S. P., Tucker, E. C., La Brooy, J., Schoeman, M. N., & Andrews, J. M. (2016). Establishing a fecal microbiota transplant service for the treatment of clostridium difficile infection. Clinical Infectious Diseases, 62(7), 908–914. https://doi.org/10.1093/cid/civ994

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free